Neoadjuvant Platinum Ameliorates Patient Selection for Adjuvant Therapy by Increasing pathologic Response Rate in Triple Negative and ER-low Breast Cancer

First Author / 第一作者

Pei-Wei Huang

Institution / 單位

Department of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan. Department of Hematology-Oncology, Jen-AI Hospital, Taichung, Taiwan

Audio / 音訊檔

Author Group / 作者群

Pei-Wei Huang, M.D. 1,4 Yung-Chang Lin, M.D. 1 Wen-Chi Shen, 1 M.D. Yun-Feng Lo, 2 M.D. Shih-Che Shen, 2 M.D. Wen-Lin Kuo, 2 M.D. Hsiu-Pei Tsai, 2 M.D. Chan-Keng Yang, 1 M.D. Meng-Ting Peng, 1 M.D. Li-Yu Lee, 3 M.D. Shir-Hwa Ueng, 3 M.D. Shin-Cheh Chen, 2* M.D. Hsien-Kun Chang, 1* M.D.

Author Group Institution/ 作者群單位

1 Department of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan. 2 Department of General Surgery, Division of Breast Surgery, Chang Gung Memorial Hospital, Chang Gung University Medical College, Linkou Branch, Taoyuan 333, Taiwan. 3 Department of Pathology, Chang Gung Memorial Hospital at Linkou, Chang Gung University College of Medicine, Taoyuan, Taiwan. 4 Department of Hematology-Oncology, Jen-AI Hospital, Taichung, Taiwan

Category / 主題分類

Clinical Research

Keyword / 關鍵字

Triple-negative breast cancer, Platinum, Neoadjuvant, Pathologic response rate

Back to list